Literature DB >> 16043754

Clinical significance of urinary liver-type fatty acid-binding protein in patients with diabetic nephropathy.

Kumi Suzuki1, Tetsuya Babazono, Hidekazu Murata, Yasuhiko Iwamoto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16043754     DOI： 10.2337/diacare.28.8.2038

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  15 in total

1.  Urinary NGAL is a useful clinical biomarker of HIV-associated nephropathy.

Authors:  David A Sola-Del Valle; Sumit Mohan; Jen-Tse Cheng; Neal A Paragas; Meghan E Sise; Vivette D D'Agati; Jonathan Barasch
Journal:  Nephrol Dial Transplant       Date:  2011-05-09       Impact factor: 5.992

2.  Renal function in diabetic nephropathy.

Authors:  Pradeep Kumar Dabla
Journal:  World J Diabetes       Date:  2010-05-15

3.  Evaluation of urinary L-FABP as an early marker for diabetic nephropathy in type 2 diabetic patients.

Authors:  Thuy Ngan Duong Thi; Binh Nguyen Gia; Huong Lan Le Thi; Thu Nguyen Cuc Thi; Huong Phung Thanh
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

4.  Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury.

Authors:  Michael A Ferguson; Vishal S Vaidya; Sushrut S Waikar; Fitz B Collings; Kelsey E Sunderland; Costas J Gioules; Joseph V Bonventre
Journal:  Kidney Int       Date:  2009-11-25       Impact factor: 10.612

Review 5.  Historical chronology of basic and clinical research in diabetic nephropathy and contributions of Japanese scientists.

Authors:  Jun Wada; Hirofumi Makino
Journal:  Clin Exp Nephrol       Date:  2009-04-11       Impact factor: 2.801

6.  Relationship of urinary liver-type fatty acid-binding protein with cardiovascular risk factors in the Japanese population without chronic kidney disease: Sasayama study.

Authors:  Yoshimi Kubota; Aya Higashiyama; Mikio Marumo; Masami Konishi; Yoshiko Yamashita; Tomonori Okamura; Yoshihiro Miyamoto; Ichiro Wakabayashi
Journal:  BMC Nephrol       Date:  2021-05-21       Impact factor: 2.388

7.  Current Metabolic Status Affects Urinary Liver-Type Fatty-Acid Binding Protein in Normoalbuminuric Patients With Type 2 Diabetes.

Authors:  Hiroyuki Ito; Hitomi Yamashita; Mina Nakashima; Akifusa Takaki; Chiduko Yukawa; Suzuko Matsumoto; Takashi Omoto; Masahiro Shinozaki; Shinya Nishio; Mariko Abe; Shinichi Antoku; Mizuo Mifune; Michiko Togane
Journal:  J Clin Med Res       Date:  2017-02-21

8.  Tubular and glomerular injury in diabetes and the impact of ACE inhibition.

Authors:  Stine E Nielsen; Takeshi Sugaya; Lise Tarnow; Maria Lajer; Katrine J Schjoedt; Anne Sofie Astrup; Tsuneharu Baba; Hans-Henrik Parving; Peter Rossing
Journal:  Diabetes Care       Date:  2009-06-05       Impact factor: 19.112

Review 9.  Urinary Markers of Tubular Injury in Early Diabetic Nephropathy.

Authors:  Temesgen Fiseha; Zemenu Tamir
Journal:  Int J Nephrol       Date:  2016-05-16

10.  Transplantation of adipose-derived mesenchymal stem cell sheets directly into the kidney suppresses the progression of renal injury in a diabetic nephropathy rat model.

Authors:  Shunsuke Takemura; Tatsuya Shimizu; Masatoshi Oka; Sachiko Sekiya; Tetsuya Babazono
Journal:  J Diabetes Investig       Date:  2019-11-06       Impact factor: 4.232
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.